Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Marginal Zone Lymphoma, Indolent Lymphoma

Bertrand Coiffier

MD, PhD

🏢Hospices Civils de Lyon / Claude Bernard University🌐France

Emeritus Professor of Hematology

82
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Bertrand Coiffier is a legendary figure in lymphoma research who pioneered the incorporation of rituximab into lymphoma treatment through the landmark GELA LNH-98.5 trial in DLBCL, and contributed substantially to indolent lymphoma treatment frameworks including marginal zone lymphoma. His career spans decades of foundational clinical investigations in B-cell lymphomas. He has mentored a generation of French and European lymphoma specialists.

Share:

🧪Research Fields 研究领域

indolent lymphoma
rituximab lymphoma
French lymphoma group
DLBCL RCHOP
lymphoma clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Bertrand Coiffier 的研究动态

Follow Bertrand Coiffier's research updates

留下邮箱,当我们发布与 Bertrand Coiffier(Hospices Civils de Lyon / Claude Bernard University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment